In the aftermath of the COVID-19 outbreak, President Trump has discussed moving manufacturing back to the U.S. from China. He has previously inked a deal with a Taiwanese chipmaker to build a plant in Arizona.
Now, he has secured a deal to build a stockpile of medical ingredients—to reduce the nation’s dependency on foreign pharmaceuticals:
“Seeking to secure the nation’s supply of critical medications, the Trump administration has signed a $354 million contract that would create the nation’s first strategic stockpile of key ingredients needed to make medicines,” NBC News reported. Read more….